US Patent 11484652 Closed-loop blood glucose control systems and methods

Is a

Patent

Patent attributes

Patent Applicant

Diabeloop

Current Assignee

Diabeloop

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

114846520

Patent Inventor Names

Sylvain Rousson0

Maeva Doron0

Romain Blanc0

Date of Patent

November 1, 2022

Patent Application Number

166454360

Date Filed

August 1, 2018

Patent Citations

‌

US Patent 10173006 LQG artificial pancreas control system and related method

‌

US Patent 10188793 Insulin on board calculation, schedule and delivery

‌

US Patent 10194839 Method and device for assessment of a series of glucose concentration values of a body fluid of a diabetic for adjustment of insulin dosing

‌

US Patent 10194845 Orthogonally redundant sensor systems and methods

‌

US Patent 10252002 Continuous glucose monitoring injection device

‌

US Patent 10258264 Methods and systems for improving the reliability of orthogonally redundant sensors

‌

US Patent 10293101 Diabetes management system

‌

US Patent 10293108 Infusion devices and related patient ratio adjustment methods

...

Patent Primary Examiner

‌

Manuel A Mendez

An automated closed-loop blood glucose control system comprises a continuous glucose-monitoring sensor (

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

US Patent 11484652 Closed-loop blood glucose control systems and methods

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 11484652 Closed-loop blood glucose control systems and methods